US EditionAbbott plans $500 million investment in Chicagoland and Dallas, including up to 300 jobs
- Abbott Laboratories reported a 4% revenue increase to $10.36 billion, just missing analyst expectations of $10.4 billion, according to LSEG estimates.
- Adjusted earnings per share rose 11.2% to $1.09, exceeding expectations by 2 cents, as shown by LSEG data.
- CEO Robert Ford stated, "It is this diversification and execution that allows Abbott to navigate through periods of uncertainty and continually deliver sustainable growth."
- Abbott's increased investments of $0.5 billion in Illinois and Texas are expected to go live by the end of 2025.
Insights by Ground AI
Does this summary seem wrong?
18 Articles
18 Articles
All
Left
1
Center
6
Right
1
Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat
Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat expectations. The post Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat appeared first on Investor's Business Daily.
times-online.com+7 Reposted by 7 other sources
Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
First-quarter GAAP diluted EPS of $0.76; adjusted diluted EPS of $1.09First-quarter reported sales growth of 4.0 percent; organic sales growth of 6.9 percent or 8.3 percent when excluding COVID-19 testing-related sales1Reported gross margin of 52.8 percent of sales; adjusted gross…
·Valley City, United States
Read Full ArticleCoverage Details
Total News Sources18
Leaning Left1Leaning Right1Center6Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
13%
C 75%
13%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
